Claire Tiger, M.D., Ph.D.

Dr. Tiger earned her PhD in Biology from Johns Hopkins University and subsequently obtained her medical degree from the Columbia University College of Physicians and Surgeons. She completed her residency in Internal Medicine at New York-Presbyterian Hospital and her Hematology/Oncology fellowship at Columbia University Irving Medical Center.

Her research focuses on rare lymphomas, with a particular interest in developing novel therapeutic strategies and leading both early- and late-phase clinical trials. She is committed to advancing understanding of the tumor microenvironment and immune repertoire to enhance immunotherapy responses and to harness these insights for therapeutic development. In addition, she is interested in improving diagnostic methodologies for rare lymphoma subtypes.

Dr. Tiger has participated in several prestigious workshops, including the ASH Clinical Research Training Institute (CRTI), the ASCO/AACR Methods in Clinical Cancer Research (Vail) Workshop, and the SITC Clinical Immuno-Oncology Network (SCION) Workshop. At SCION, she received the Mac Cheever Award for writing the most simple and elegant clinical trial protocol. She is also the recipient of several notable honors, including the ASCO Young Investigator Award, the ASH Research Training Award for Fellows, and the Robert A. Winn Diversity in Clinical Trials Career Development Award. Dr. Tiger is an active member of the American Society of Hematology (ASH) and the ECOG Lymphoma Committee.

Outside of her clinical and research work, Dr. Tiger enjoys spending time with family and friends and is the proud mother of a three-year-old.